| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |